Today: 21 May 2026
Browse Category

UK Stocks 26 November 2025 - 10 January 2026

Antofagasta plc Stock (LSE: ANTO) News, Forecasts and Analyst Targets — What Investors Are Watching on December 13, 2025

Antofagasta plc Stock (LSE: ANTO) News, Forecasts and Analyst Targets — What Investors Are Watching on December 13, 2025

Antofagasta shares closed at 2,932p on December 12, near a 52-week high set at £30.95 on December 5. The stock is up about 72% over the past year, tracking copper’s 35% surge in 2025 as prices approach $12,000 per ton. Analyst targets now mostly sit below current levels. Copper supply is forecast to remain tight into 2026, with deficits of 124,000 tons this year and 150,000 tons next.
13 December 2025
Most Active UK Stocks Today: Lloyds, BP, Magnum Ice Cream and Vodafone Lead FTSE 100 on 11 December 2025

Most Active UK Stocks Today: Lloyds, BP, Magnum Ice Cream and Vodafone Lead FTSE 100 on 11 December 2025

The FTSE 100 closed up 0.1% at 9,666 on Thursday, with heavy trading in financials, energy, and consumer stocks after the US Federal Reserve’s rate cut. Lloyds Banking Group led volumes, slipping nearly 1% as Exane BNP downgraded the stock to “neutral” following a strong rally and the completion of a £1.7bn buyback. Unilever, Rolls-Royce, BP, and British American Tobacco also saw high value turnover.
Biggest UK Stock Gainers Today (9 December 2025): Saga, Kainos and Empire Metals Lead London’s Winners

Biggest UK Stock Gainers Today (9 December 2025): Saga, Kainos and Empire Metals Lead London’s Winners

Saga plc jumped 8.36% to 317.50p on Monday, leading UK gainers after Kernow Asset Management predicted a 400% upside for the stock. Kainos Group rose 6.65%, Empire Metals added 5.98%, PayPoint gained 5.13%, and CRH advanced 4.88%. The FTSE 100 closed subdued as rising gilt yields and a weaker pound weighed on the broader market.
Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

The FTSE 100 closed down 0.2% at 9,645.09 on Monday, with heavy trading concentrated in BP, Barclays, Rolls-Royce, Unilever, Lloyds, HSBC, London Stock Exchange Group, Anglo American, GSK, and British American Tobacco. Investors pulled back ahead of key US Federal Reserve and Bank of England rate decisions. FTSE 100 futures hovered near 9,657 early Tuesday, with technical signals pointing to caution.
UK Stock Market Top Gainers Today (8 December 2025): Tern, Anglesey, Kainos and Trustpilot Stand Out

UK Stock Market Top Gainers Today (8 December 2025): Tern, Anglesey, Kainos and Trustpilot Stand Out

The FTSE 100 hovered near 9,665 on Monday, little changed as investors awaited central bank decisions. Unilever weighed on blue-chips after its ice-cream spin-off. Small-cap stocks saw sharp moves, with Tern jumping 44% on heavy trading. Markets largely expect a 25 basis point Bank of England rate cut on 18 December.
Best UK Stocks to Buy Now (8 December 2025): 7 FTSE Shares for Growth, Income and Value

Best UK Stocks to Buy Now (8 December 2025): 7 FTSE Shares for Growth, Income and Value

The FTSE 100 is up nearly 20% year-to-date as of December 8, 2025, reaching record highs in August and November. UK equities have attracted renewed global interest, aided by Bank of England rate cuts and a weaker pound. Large investors are shifting funds from US tech stocks to UK shares. Today, the FTSE 100 remains near recent highs, with markets awaiting further rate decisions.
8 December 2025
Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

The FTSE 100 is up about 22–23% year-to-date as of December 5, 2025, and sits less than 2% below its record closing high. Today, the FTSE 100 rose 0.2% and the FTSE 250 gained 0.4%, with AstraZeneca and Ocado among notable risers. Markets expect the Bank of England to cut rates from 4% to 3.75% on December 18. UK equities continue to trade at a discount to global peers.
UK Stock Market Today, 3 December 2025: FTSE 100 Slips as Banks Sink, Miners Shine and WPP Faces FTSE 100 Exit

UK Stock Market Today, 3 December 2025: FTSE 100 Slips as Banks Sink, Miners Shine and WPP Faces FTSE 100 Exit

The FTSE 100 closed down 0.1% at 9,693 on Wednesday, just below record highs, as UK banks fell after the FCA announced it would resume handling motor-finance complaints in May 2026. Lloyds, Barclays, HSBC, and Close Brothers all declined. The FTSE 250 ended flat after earlier losses. Miners and energy stocks gained, while investors prepared for a December FTSE index reshuffle.
National Grid plc Stock on 2 December 2025: Share Price, Dividend Yield and 2026 Forecasts

National Grid plc Stock on 2 December 2025: Share Price, Dividend Yield and 2026 Forecasts

National Grid shares closed at 1,149.44p in London on December 2, 2025, near their 52-week high after rising about 19% this year. Half-year results showed underlying operating profit up 13% to £2.29 billion and record capital investment of £5.05 billion. Net debt reached £41.8 billion. The group’s performance slightly exceeded analyst forecasts.
UK Stock Market Wrap, 28–29 November 2025: FTSE 100 Ends Winning Streak as Reeves’ Budget and AI Bubble Fears Loom

UK Stock Market Wrap, 28–29 November 2025: FTSE 100 Ends Winning Streak as Reeves’ Budget and AI Bubble Fears Loom

The FTSE 100 closed Friday at 9,720.51, up 0.3% on the day and 1.7% for the week, but slipped 0.2% for November, ending a four-month winning streak. The FTSE 250 rose 0.3% Friday yet fell 1.4% over the month. Oil and gas stocks gained 1.3% Friday, while Mitchells & Butlers surged over 11% on strong annual profits. Chancellor Rachel Reeves’ tax-heavy budget triggered the week’s biggest market moves.
29 November 2025
Spectris (LON: SXS) Share Price Today, 26 November 2025 – Fresh Stake Disclosures as KKR’s £41.75 Takeover Nears the Finish Line

Spectris (LON: SXS) Share Price Today, 26 November 2025 – Fresh Stake Disclosures as KKR’s £41.75 Takeover Nears the Finish Line

Spectris shares traded around 4,132p–4,134p in London on Monday, less than 1% below the £41.75 per share takeover offer from KKR-backed Project Aurora Bidco. Trading was subdued, with activity focused on disclosure filings including a major holdings notice from JPMorgan Chase, which lifted its economic interest above 8%. No new terms or surprises emerged.

Stock Market Today

  • Stock Market Today: Key Insights for May 21 Trading
    May 20, 2026, 10:27 PM EDT. Stocks in the news and major brokerage calls shape market sentiment as traders prepare for May 21. This report provides a complete trade setup, highlighting critical market movements and strategies. Stay informed with the essential data before entering trades today.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop